Sangui Biotech International, Inc. revenue reports
Sangui Biotech International, Inc. financial reports, Sangui Biotech International, Inc. annual revenue in 2024. When does Sangui Biotech International, Inc. report revenue?
Sangui Biotech International, Inc. total revenue, net income and dynamics of changes in Euro today
Sangui Biotech International, Inc. revenue for the past few reporting periods. The dynamics of Sangui Biotech International, Inc. net revenue grew by 10 490 € compared to the previous report. Net income of Sangui Biotech International, Inc. today amounted to -90 €. Graph of the financial report of Sangui Biotech International, Inc.. The financial report on the chart of Sangui Biotech International, Inc. allows you to clearly see the dynamics of fixed assets. Information on Sangui Biotech International, Inc. net income on the chart on this page is drawn in blue bars.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021
19 722.09 €
+162.74 % ↑
-83.80 €
-
31/12/2020
9 955.09 €
-8.482 % ↓
-68 795.49 €
-
30/09/2020
18 509.83 €
+6 949.650 % ↑
-69 726.57 €
-
30/06/2020
7 205.61 €
-68.505 % ↓
-64 535.81 €
-
31/12/2019
10 877.78 €
-
-50 262.38 €
-
30/09/2019
262.56 €
-
-39 802.65 €
-
30/06/2019
22 878.45 €
-
-103 204.41 €
-
31/03/2019
7 506.35 €
-
-61 835.68 €
-
Show:
to
Sangui Biotech International, Inc. financial report charts
Dates of Sangui Biotech International, Inc. finance reports: 31/03/2019, 31/12/2020, 31/03/2021. The dates of the financial statements are determined by the accounting rules. The latest financial report of Sangui Biotech International, Inc. is available online for such a date - 31/03/2021. Gross profit Sangui Biotech International, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Sangui Biotech International, Inc. is 21 182 €
Sangui Biotech International, Inc. quarterly report dates
Total revenue Sangui Biotech International, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Sangui Biotech International, Inc. is 21 182 € Operating income Sangui Biotech International, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Sangui Biotech International, Inc. is -28 325 € Net income Sangui Biotech International, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Sangui Biotech International, Inc. is -90 €
Current assets Sangui Biotech International, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Sangui Biotech International, Inc. is 54 570 € Total assets Sangui Biotech International, Inc. refers to the total amount of assets owned by a person or entity. Total assets Sangui Biotech International, Inc. is 126 324 € Current cash Sangui Biotech International, Inc. - the sum of all of the cash a company has on the date of report. Current cash Sangui Biotech International, Inc. is 11 620 €
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/12/2019
30/09/2019
30/06/2019
31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
19 722.09 €
9 955.09 €
18 509.83 €
7 205.61 €
10 877.78 €
262.56 €
22 878.45 €
7 598.53 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
-
-
-
-
-
-
-
-92.18 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
19 722.09 €
9 955.09 €
18 509.83 €
7 205.61 €
10 877.78 €
262.56 €
22 878.45 €
7 506.35 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-26 372.78 €
-35 664.01 €
-41 349.17 €
-47 957.97 €
-34 015.07 €
-52 045.40 €
-102 278.92 €
-69 039.43 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-83.80 €
-68 795.49 €
-69 726.57 €
-64 535.81 €
-50 262.38 €
-39 802.65 €
-103 204.41 €
-61 835.68 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
1 918.02 €
1 857.50 €
2 259.73 €
1 759.74 €
2 467.36 €
2 081.89 €
6 376.02 €
4 741.05 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
46 094.88 €
45 619.10 €
59 859 €
55 163.58 €
44 892.86 €
52 307.96 €
125 157.37 €
76 545.78 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
50 808.93 €
37 831.56 €
61 432.53 €
45 339.77 €
49 335.96 €
38 257.06 €
73 528.16 €
47 263.38 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
117 617.50 €
112 819.65 €
138 517.41 €
116 690.14 €
52 131.06 €
42 595.89 €
73 528.16 €
47 263.38 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
10 819.13 €
8 231.66 €
19 669.02 €
14 228.73 €
14 333.95 €
19 166.24 €
25 560.88 €
17 251.94 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
653 223.84 €
590 267.14 €
624 716.09 €
492 614.75 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
653 223.84 €
590 267.14 €
624 716.09 €
492 614.75 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
1 253.04 %
1 385.74 %
849.63 %
1 042.28 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
-217 146.01 €
-216 794.99 €
-147 317.02 €
-77 187.30 €
-1 864.02 €
50 497.95 €
45 811.83 €
146 120.59 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
-44 336.07 €
-29 103.64 €
-74 979.71 €
-84 900.35 €
Last revenue report of Sangui Biotech International, Inc. was 31/03/2021. According to last financial report total revenue in Sangui Biotech International, Inc. was 19 722.09 Euro and changed by +162.74% since last year. Net income in Sangui Biotech International, Inc. was -83.80 € in last quartal, net income changes to 0%.
Sangui Biotech International, Inc. stocks data
SBH.HM stock price
Sangui Biotech International, Inc. stock price today, SBH.HM stock quote.
